Evidence map›Paper›PMID 40443240›Full record

ArticleJournal of microbiology and biotechnology2025

A Nasal Vaccine Displaying Anthrax Antigen on the Surface of

In-Hwan Jang, In Ryeong Jung, Hyojung Suh, Hyo-Joo Ahn, Donghyun Kim, Youn Soo Choi, June-Yong Lee, Kyung-Ah Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A Safe and Versatile Minicell Platform Derived fromJournal of microbiology and biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

In-Hwan JangDepartment of Microbiology & Immunology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
In Ryeong JungDepartment of Microbiology and Immunology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Hyojung SuhDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080 Republic of Korea.
Hyo-Joo AhnSaeloun Bio Inc., Seoul 08826, Republic of Korea.
Donghyun KimDepartment of Microbiology & Immunology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Youn Soo ChoiDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080 Republic of Korea.
June-Yong LeeDepartment of Microbiology and Immunology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Kyung-Ah LeeSaeloun Bio Inc., Seoul 08826, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthrax, particularly inhalational anthrax, poses a severe threat due to its high fatality rate and potential misuse as a biological weapon. Current anthrax vaccines require multiple injections, which limits their practicality and underscores the need for improved, user-friendly vaccination strategies. In this study, we developed a novel nasal booster vaccine platform aimed at preventing inhalational anthrax by inducing mucosal immunity at the pathogen's entry site, the respiratory tract. We successfully engineered a biologically safe

Indexed as

AnthraxAnthrax VaccinesAntigens, BacterialBacterial ToxinsImmunity, MucosalLactiplantibacillus plantarumAdministration, IntranasalAnimalsAntibodies, BacterialBacillus anthracisFemaleImmunization, SecondaryImmunoglobulin AMiceMice, Inbred BALB Canthrax toxinAnthrax VaccinesAntibodies, BacterialAntigens, BacterialBacterial ToxinsImmunoglobulin AAnthraxLactiplantibacillus plantarumnasal vaccineprotective antigen

Identifiers

PMID40443240
PMCPMC12149394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.